Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
35.98
+1.27 (3.66%)
At close: Jul 19, 2024, 4:00 PM
35.91
-0.07 (-0.19%)
After-hours: Jul 20, 2024, 12:58 PM EDT

BHVN Statistics

Total Valuation

BHVN has a market cap or net worth of $3.18 billion. The enterprise value is $2.92 billion.

Market Cap 3.18B
Enterprise Value 2.92B

Important Dates

The next estimated earnings date is Monday, July 29, 2024, before market open.

Earnings Date Jul 29, 2024
Ex-Dividend Date n/a

Share Statistics

BHVN has 88.29 million shares outstanding. The number of shares has increased by 19.64% in one year.

Shares Outstanding 88.29M
Shares Change (YoY) +19.64%
Shares Change (QoQ) +1.97%
Owned by Insiders (%) 12.85%
Owned by Institutions (%) 86.20%
Float 76.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 10.54
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.09.

Current Ratio 4.03
Quick Ratio n/a
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -147.10% and return on invested capital (ROIC) is -164.83%.

Return on Equity (ROE) -147.10%
Return on Assets (ROA) -113.60%
Return on Capital (ROIC) -164.83%
Revenue Per Employee n/a
Profits Per Employee -$2.16M
Employee Count 239
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -1.75M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +40.93% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +40.93%
50-Day Moving Average 35.66
200-Day Moving Average 39.75
Relative Strength Index (RSI) 50.62
Average Volume (20 Days) 1,255,116

Short Selling Information

The latest short interest is 9.85 million, so 11.16% of the outstanding shares have been sold short.

Short Interest 9.85M
Short Previous Month 9.83M
Short % of Shares Out 11.16%
Short % of Float 12.85%
Short Ratio (days to cover) 6.07

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -541.51M
Pretax Income -518.93M
Net Income -517.18M
EBITDA -512.22M
EBIT -518.93M
Earnings Per Share (EPS) -$6.89
Full Income Statement

Balance Sheet

The company has $283.42 million in cash and $27.09 million in debt, giving a net cash position of $256.33 million or $2.90 per share.

Cash & Cash Equivalents 283.42M
Total Debt 27.09M
Net Cash 256.33M
Net Cash Per Share $2.90
Equity (Book Value) 301.45M
Book Value Per Share 3.41
Working Capital 262.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$356.72 million and capital expenditures -$2.75 million, giving a free cash flow of -$359.48 million.

Operating Cash Flow -356.72M
Capital Expenditures -2.75M
Free Cash Flow -359.48M
FCF Per Share -$4.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BHVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -19.64%
Shareholder Yield -19.64%
Earnings Yield -16.28%
FCF Yield -11.32%
Dividend Details

Analyst Forecast

The average price target for BHVN is $54.71, which is 52.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target $54.71
Price Target Difference 52.06%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2